HEPATOBILIARY SPECTRUM IN IBD: A Hospital-Based Case Series

Dr. Samsar Naouel

2 weeks ago

2,947 2 minutes read

Presented in 15th World Gastroenterology, IBD & Hepatology Conference from December 17-19, 2025, in Dubai, UAE & Online.

Poster Presenter Name: Dr. Samsar Naouel , M.D., Ph.D.
Organization: Oran University Hospital, Faculty of medecine Oran
Location: Algeria
Research Interest: IBD , endoscopy, proctologic surgery
Category: Poster Presentation

SAMSAR.¹ , M. AMAR.², N.KORTI ³

Biography: Dr. Samsar Naouel is an Assistant Professor in Hepato-Gastroenterology since 2021 at the University Hospital of Oran (CHU Oran), affiliated with the Faculty of Medicine, University of Oran 1. She is currently working on her doctoral thesis, which focuses on Crohn’s disease. Her clinical and research activities are conducted within the Hepato-Gastroenterology ward of CHU Oran. Hospital-based academic researcher and lecturer at the Faculty of Medicine, University of Oran.

Global Journal of Gastroenterology & Hepatology Research [GJGHR]
Visit Poster Presenter page: https://gastroenterology.utilitarianconferences.com/speaker/dr-samsar-naouel

Introduction: In inflammatory bowel diseases (IBD), extra-intestinal manifestations occur in approximately 50% of cases, with hepatobiliary abnormalities being the most frequent. Their progression may sometimes be independent of the IBD course.

Materials and Methods: This is a retrospective descriptive study conducted over a period of 2 years (May 2021 – August 2023), including patients followed in the Hepato-Gastroenterology Department “A” for IBD eligible for biologic therapy, in whom hepatobiliary abnormalities were diagnosed. Patients receiving immunosuppressive treatment were ex-cluded.

Conclusion: Hepatobiliary manifestations are often underrecognized and overshadowed by digestive symptoms. Their systematic investigation should not overlook common causes of liver disease, in order to ensure appropriate manage-ment and improve the prognosis of IBD.

Keywords: IBD – Hepatobiliary manifestations – PSC

References:
– Mendes(2007). Abnormal Hepatic Biochemistries in Patients With Inflammatory Bowel Disease.

– Nancey (2012), Screening of biliary and liver diseases in inflammatory bowel disease. Consequences on the therapeutic management.

– Chtourou (2019). Manifestations hépatobiliaires au cours des maladies inflammatoires chroniques de l’intestin.

– Losurdo, WJH (2021) Liver involvement in inflammatory bowel disease: What should the clinician know?

#HepatobiliarySpectrum #IBDResearch #Hepatology #Gastroenterology #IBDConference #LiverAndGut #GutLiverAxis #HepatobiliaryDiseases #InflammatoryBowelDisease #ClinicalGastro #HospitalBasedStudy #CaseSeries #GIResearch #LiverHealth #DigestiveDiseases #HepaticComplications #BiliaryDisorders #IBDInsights #TranslationalMedicine #MedicalResearch #GlobalGastro #HepatoGastro #GIHepatology #EvidenceBasedMedicine #ClinicalCases #IBDScience #LiverInIBD #AcademicMedicine #GastroUpdate #HepatologyUpdate #GIConference #MedicalConference #ResearchPresentation #GlobalHealthResearch #DigestiveHealth #IBDCommunity #LiverCare #GastroScholars #HepatoBiliary #GutHealthMatters #IBDAwareness #MedicalInnovation #GIExperts #HepatologyResearch #ClinicalGastroenterology #WorldGastro #ScienceInMedicine